- Home
- SACH vs BEAT Comparison
SACH vs BEAT Comparison
Compare SACH & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SACH | BEAT |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | 27 | 16 |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 44.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SACH | BEAT |
|---|---|---|
| Price | $1.06 | $1.19 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $2.00 | ★ $5.63 |
| AVG Volume (30 Days) | 193.7K | ★ 729.5K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 19.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.00 | N/A |
| Revenue Next Year | $6.80 | $260.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $0.54 |
| 52 Week High | $1.35 | $4.00 |
Technical Indicators
Market Signals| Indicator | SACH | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 42.59 |
| Support Level | $1.05 | $1.17 |
| Resistance Level | $1.12 | $1.32 |
| Average True Range (ATR) | 0.05 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 88.83 | 45.00 |
Price Performance
Historical ComparisonAbout SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.